HLA Typing for Transplant Market Analysis And Forecast To 2031: By Technology (Non-Molecular Assays, Molecular Assays), By Product and Services (Instruments, Reagents & Consumables, Software, Services), By Application (Diagnostics, Research), By End-use (

HLA Typing for Transplant Market Analysis And Forecast To 2031: By Technology (Non-Molecular Assays, Molecular Assays), By Product and Services (Instruments, Reagents & Consumables, Software, Services), By Application (Diagnostics, Research), By End-use (Hospitals, Academic & Research Institutes) And Region

The global HLA Typing for Transplant Market was valued at USD 667.8 Million in 2021 and it is anticipated to grow up to USD 1189.6 Million by 2031, at a CAGR of 5.9% during the forecast period.

HLA typing is a laboratory test that is performed on a sample of a persons blood in order to determine their human leukocyte antigen (HLA) type. This information is used to match individuals with a compatible donor for bone marrow or stem cell transplants. HLA typing is performed using a technique called DNA sequencing. This involves taking a sample of blood and extracting the DNA. The DNA is then analyzed to identify the specific sequence of nucleotides (the building blocks of DNA) that make up the persons HLA type.
Global HLA Typing for Transplant Market Scope and Report Structure
[table id=591 /]
Market Trends and Drivers
Technological advancements in molecular assays segment are driving the global HLA Typing for transplant market progression. Presently, target specific PCR method is used to screen disease causative pathogen. Also, companies are focusing on development of novel platforms for HLA typing.
Market Restraints and Challenges
Increasing utilization of molecular diagnostics in HLA typing has led to upsurge in its costs. Rising demand for molecular diagnostics due to its ability to deliver accurate results in less time has created pressure on industry players to develop new products and to satisfy growing consumer demands. Majority of laboratories perform several molecular tests using hematology and chemistry analyzers. Additionally, as per the National Human Genome Research Institute, gene sequencing test cost around USD 5,000 to USD 10,000 per test which is not affordable to majority of population.
Global HLA Typing for Transplant Market Segmental Overview


The report analyses the global HLA Typing for Transplant Market based on technology, product & services, application, end-use, and region.

Global HLA Typing for Transplant Market by Technology



Based on the technology, the HLA typing for transplant market industry is bifurcated into g Non-molecular assays, and Molecular assays. Of these, the molecular assay segment registered revenue of around USD 2.72 billion in 2021. The molecular assays segment dominated the market share in 2021. Growing demand for molecular assays and increasing adoption rate along with advanced technologies that encourage customer buying behaviour are the major factors driving the industry expansion during the forecast timeframe. Also, associated advantages provided by molecular techniques are effective as compared to non-molecular assays that boost the demand for molecular assays segment growth.

The molecular assays are sub-classified into PCR based and sequencing based molecular assays. PCR technique is used for fast recognition of pathogens thus, became popular among the healthcare professionals and patients, thereby supplementing the industry revenue. Moreover, together with conventional PCR methods, the real-time PCR (RT-PCR) has developed as innovative technology and is increasingly being used in research laboratories and clinical diagnostics.

Global HLA Typing for Transplant Market by Product and Services



By product and services, the industry is divided into Instruments, Reagents and consumables, Software, and Services. The Reagents and consumables segment of the HLA typing for transplant market is expected to grow at a rapid pace through 2031. The reagents and consumables segment in the HLA typing for transplant market exceeded highest market share in 2021. Reagents and consumables are used in large quantity and are frequently required for performing HLA typing. Thus, rising acceptance of reagents and consumables in transplant diagnostic technique is poised to impel the industry progression. Also, introduction of recent technologies causing development as well as enhancement of instruments stimulates the segment expansion in coming years. In addition, availability of diverse types of kits such as SBT kits (sequencing-based typing), SSO kits (sequence-specific oligonucleotides), SSP kits (sequence-specific primers) will stimulate the segment value.

.Global HLA Typing for Transplant Market by Application



Based on applications, the HLA typing for transplant market industry is categorized diagnostics and research. The diagnostics segment accounted for lucrative market share in 2021. This is owing to the wide-ranging application in disease diagnosis coupled with availability of advanced and more specific gene testing techniques. Additionally, increasing implementation of HLA typing with PCR and other sequencing devices in healthcare administrations including diagnostics and advancements in research & development activities will accelerate the industry value. Moreover, the need for HLA matched bone marrow transplantation treatment for couples at risk with thalassaemic children is further slated to propel the industry size.

Global HLA Typing for Transplant Market by End-use



Based on the end-user, the industry is categorized into hospitals, diagnostic labs, academic and research institutes. Among these, the diagnostic labs segment is expected to depict significant CAGR from 2022 to 2031. impelled by the increasing number of HLA testing due to high demand for transplant procedures. For instance, according to the Global Observatory on Donation & Transplantation, nearly 157,301.0 organ transplantation were performed in 2019. The report also stated that, around 150,407.0 organ transplantation were performed in 2018.
Geographical Analysis of Global HLA Typing for Transplant Market


Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America HLA typing for transplant market captured significant market share in 2021 and is poised to grow substantially during the forthcoming years. This is due to the increased demand for organ transplant coupled with rising governments initiatives to support ethical progress of organ donation and transplantation programs. Moreover, presence of prominent players that offer advanced technologies will fuel the business growth. Factors such as large number and sizes of laboratories and availability of highly skilled professionals in the region is set to propel the regional growth. Furthermore, Availability of large number of laboratories and highly skilled professionals in the region will further boost the regional expansion.
Major Players in the Global HLA Typing for Transplant Market
The key players in the market Abbott, Bio-Rad Laboratories, CareDx, Qiagen N.V., Thermo Fischer Scientific, F. Hoffmann-La Roche Ltd, Illumina Inc., Luminex Corporation and Immucor, Inc, Hologic, Inc., Luminex, and Biofortuna, among others.
COVID-19 Impact
The spread of COVID-19 pandemic across the globe had a minimal impact on market in 2020. Various companies registered a slowdown in testing service volumes in the final weeks of March and during April 2020 as well as faced significant challenges in exporting the products. This can be credited to increasing number of COVID-19 infections along with restrictions, delaying or postponing of the non-essential surgical including organ transplant and non-invasive procedures. These procedures are not considered as critical or life-saving procedure and hence, come under elective surgical procedures. Healthcare organizations were performing more out-patient elective surgical procedures, as countries and states begin to ease few COVID-19 restrictions. However, securing slots for bone marrow harvest makes extremely difficult for lab technicians and hospitals, as health care organizations have a backlog of surgeries. This provision of suboptimal supervision may hinder HLA typing for transplant to some extent during the forecast timeframe.
Recent Developments

In September 2022, Qiagen announced new additions to its NeuMoDx assay menu for organ transplant-associated viruses.
In July 2022, Qiagen expanded PCR portfolio, launches custom assay service
In August 2021, QIAGEN and GT Molecular collaborated to offer a complete SARS-CoV-2 wastewater detection solution based on QIAcuity Digital PCR technology
In April 2021, CareDx announced that they have launched a fully-functional next generation sequencing (NGS) HLA typing service lab in Stockholm, Sweden to support companies in research and academic studies working on HLA applications in vaccine and drug development as well as disease association studies.

HLA Typing for Transplant Market Report Coverage

The report offers a comprehensive quantitative as well as qualitative analysis of the current global HLA Typing for Transplant Market outlook and estimations from 2021 to 2031, which helps to recognize the prevalent opportunities.
A thorough analysis of market trends and restraints is provided.
Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
The forecasts in this report are made by examining the recent trends along with future HLA Typing for Transplant Market potential from 2021 to 2031 in terms of revenue.
Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the HLA Typing for Transplant Market are also analyzed.
Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global surface disinfectants industry.

Frequently Asked Questions

Q1. How big is the HLA typing for transplant Market?

Ans. The global HLA Typing for Transplant Market size was USD 667.8 Million in 2021 and is anticipated to reach USD 1189.6 Million in 2031, growing at a rate of 5.9% from 2022 to 2031.

Q2. What is the HLA Typing for Transplant Market growth rate?

Ans. The growth rate of the HLA Typing for Transplant Market is 5.9%.

Q3. Which region holds a major market share for the market?

Ans. North America holds a major market share of the HLA Typing for Transplant Market in 2021.

Q4. Which segment accounted for the largest HLA Typing for Transplant Market share?

Ans. By end-use segment accounted for the largest HLA Typing for Transplant Market share.

Q5. Who are the key players in the Nutricosmetics Market?

Ans. The global HLA Typing for Transplant Market report includes players such Abbott, Bio-Rad Laboratories, CareDx, Qiagen N.V., Thermo Fischer Scientific, F. Hoffmann-La Roche Ltd, Illumina Inc., Luminex Corporation and Immucor, Inc, Hologic, Inc., Luminex, and Biofortuna, among others.

Q6. What are the factors driving the HLA Typing for Transplant Market growth?

Ans. The major factors driving the growth of the market are Increasing number of solid organ transplant couled with technological advancements.

Q7. What are the key growth strategies of HLA Typing for Transplant Market players?

Ans. The key growth strategies of HLA Typing for Transplant Market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the HLA Typing for Transplant Market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the HLA Typing for Transplant Market during the forecast period.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.